Page 45 - JCTR-9-5
P. 45

Journal of Clinical and Translational Research 2023; 9(5): 347-356




                                        Journal of Clinical and Translational Research

                                               Journal homepage: http://www.jctres.com/en/home


        REVIEW ARTICLE

        Heart failure research paradigms using bedside observation on endothelial

        muscle common denominators to highlight important translational
        questions



        Pupalan Iyngkaran *, Fahad Hanna , Maximilian De Courten , Sharmalar Rajendran 4
                                                              3
                        1,2
                                        2
                                                                          2
        1 Melbourne Clinical School, The University of Notre Dame, Melbourne, Victoria, Australia,  Program of Public Health, Torrens University Australia,
        Melbourne, Victoria, Australia,  Mitchell Institute, Victoria University, Melbourne, Victoria, Australia,  Northern Adelaide Local Health Network,
                                                                                  4
                               3
        South Australia, Australia
        ARTICLE INFO                        ABSTRACT
        Article history:                    Background  and Aim: Congestive  heart  failure  (CHF) imposes a  relevant  burden  on  healthcare
        Received: January 11, 2023          systems, as it is associated with high morbidity and mortality rates and considerable costs. Within
        Revised: July 17, 2023              the last three to four decades, there have been revolutionary  advancements,  particularly  in the
        Accepted: August 16, 2023           pharmaceutical industry. In addition, health services research at the population level has also delivered.
        Published: September 30, 2023       A third avenue for advancing the clinical management of CHF is to explore established therapies with
                                            a new approach. In this perspective, we explore these established concepts and provide impetus for
        Keywords:                           using bedside observations to find improvements in CHF outcomes.
        Clinical translation                Conclusion: There are potentially new concepts that can be brought to established solutions for CHF.
        Congestive heart failure            Encouraging observations when delivering established guideline-directed medical therapies are issues
        Endothelial dysfunction             that the evidence-based medicine community should factor alongside novel discoveries to improve
        Nitric oxide                        CHF prognosis. An emphasis on innovating on the known can be considered as an important paradigm
        Skeletal muscle                     for discovery.
                                            Relevance for Patients: Patients with CHF receiving current available treatments have improved
        *Corresponding author:              outcomes; however, those not improving could be considered under evolving research paradigms.
        Pupalan Iyngkaran
        Melbourne Clinical School, The University of
        Notre Dame, Melbourne, Victoria, Australia.
        Program of Public Health, Torrens University,   1. Introduction
        Melbourne, Victoria Australia.
        E-mail: pupalan.iyngkaran@student.torrens.  Congestive  heart  failure  (CHF) as  a  syndrome  has  advanced  considerably  with  the
        edu.au                              understanding  of  pathophysiology  and  in  delivering  prognostic  treatments.  The  latest
                                            guidelines published by American and European cardiac societies provide a comprehensive
        © 2023 Author(s). This is an Open-Access   outline of strategies and proven therapies for holistic CHF  disease management  [1,2].
        article distributed under the terms of the   Guideline-directed medical therapies (GDMTs) will improve outcomes, nonetheless, the
        Creative Commons Attribution-Noncommercial   debate  will  continue  in regions where there  are poorer outcomes.  Thus, there is merit
        License, permitting all non-commercial use,
        distribution, and reproduction in any medium,   in  reflecting  on  what  has  been  achieved.  In  particular,  understanding  where  and  why
        provided the original work is properly cited.  there are gaps in achieving trial findings when GDMTs are prescribed at the population
                                            level [3-6]. Clinical translation and health services research has addressed some of these
                                            external validity factors [7,8]. A second factor on validity that may be intrinsic to patients
                                            is not easily standardised for in trials and randomisation and can be masked when data is
                                            pooled; importantly, it can be assessed at the bedside when treatments are administered, and
                                            responses are observed [9]. There is thus the intersection with post-trial prescribing in the
                                            clinical domain, and to fully capture what transpires requires a collaborative mindset and
                                            an administrative framework to deliver to patients the GDMT and learn of emerging gaps.
                                           DOI: http://dx.doi.org/10.18053/jctres.09.202305.23-00010
   40   41   42   43   44   45   46   47   48   49   50